Portable surface-enhanced Raman spectroscopy (SERS)

John Gilmore, Hamamatsu Corporation
November 14, 2018

Portable surface-enhanced Raman spectroscopy (SERS) detection of opioid-related drugs such as fentanyl could prove to be a very useful technique for drug control officials and health agencies that work with controlled substance affected individuals and communities. This presentation provides a comprehensive overview of portable, nanostructure-based SERS technology and gives examples of how this technology can be used for trace detection of fentanyl and over-the-counter drugs. Based on a collaboration between Rutgers University and Hamamatsu Corporation.

About the presenter

John D. Gilmore is Business Development Manager at Hamamatsu Corporation. He is currently involved with the development of spectrometer business, photonics based laboratory experiments, general spectrometer and Raman Module marketing, business development and advanced technical support at Hamamatsu’s U.S. headquarters in Bridgewater, NJ.

Scroll to Top